Shionogi & Co.,Ltd. (4507) Earnings Releases & Disclosures
| Date | Type | Title | Files |
|---|---|---|---|
| 2026-11-11 | Earnings Release | (Corrections / Correction of Numerical Data) Corrections to the Consolidated Financial Results for the Second Quarter of Fiscal Year 2026 (IFRS) | |
| 2026-11-11 | Earnings Release | (Corrections / Correction of Numerical Data) Corrections to the Consolidated Financial Results for the First Quarter of Fiscal Year 2026 (IFRS) | |
| 2026-11-10 | — | Notice Regarding Bridge Loan Financing in Connection with the Acquisition of IntraBio Inc. | |
| 2026-10-30 | Earnings Release | Notice of Partial Correction to “Notice of Revisions to Earnings Forecasts and Dividend Forecasts (Dividend Increase)” | |
| 2026-10-29 | — | Notice Regarding Interim Dividend | |
| 2026-10-29 | Earnings Release | Notice of Revisions to Earnings Forecasts and Dividend Forecasts (Dividend Increase) | |
| 2026-10-29 | Earnings Release | Consolidated Financial Results for the Second Quarter of Fiscal Year 2026 (IFRS) | |
| 2026-10-29 | Earnings Release | Financial Results for the 2nd Quarter of FY2026 Supplement | |
| 2026-10-29 | Earnings Release | 1st Half (Interim Period) of Fiscal 2026 Financial Results | |
| 2026-10-05 | — | Shionogi Continues Rare Disease Expansion With Planned Acquisition of IntraBio Inc. | |
| 2026-09-16 | — | COVGOZE for Intramuscular Injection (JN.1-adapted), Recombinant Protein COVID-19 Vaccine, Receives Partial Change Approval in Japan | |
| 2026-09-16 | — | Notice Regarding Approval of an Additional Dosage and Administration of VTAMA Cream for Pediatric Atopic Dermatitis (Under Age12) in Japan | |
| 2026-08-03 | Earnings Release | Consolidated Financial Results for the First Quarter of Fiscal Year 2026 (IFRS) | |
| 2026-08-03 | Earnings Release | Financial Results for the 1st Quarter of FY2026 Supplement | |
| 2026-08-03 | Earnings Release | 1st Quarter of Fiscal 2026 Financial Resultsand HIVBusiness Update | |
| 2026-07-23 | Treasury Shares | Notice of Completion of Disposal of Treasury Shares as Restricted Stock Compensation Plan |
TDnet keeps only 31 days; this site accumulates daily and cannot backfill earlier disclosures.